mk 761 has been researched along with wb 4101 in 1 studies
| Studies (mk 761) | Trials (mk 761) | Recent Studies (post-2010) (mk 761) | Studies (wb 4101) | Trials (wb 4101) | Recent Studies (post-2010) (wb 4101) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 477 | 1 | 34 |
| Protein | Taxonomy | mk 761 (IC50) | wb 4101 (IC50) |
|---|---|---|---|
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, JJ; Gross, D; Lundell, GF; Lyon, TF; McClure, DE; Mensler, K; Raab, AW; Randall, WC; Risley, EA; Sweet, CS; Williams, M | 1 |
1 other study(ies) available for mk 761 and wb 4101
| Article | Year |
|---|---|
Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Cerebral Cortex; Dihydroalprenolol; Dioxanes; Prazosin; Pyridines; Rats; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1983 |